Spain has been a committed partner of Gavi since 2006, playing a vital role in expanding access to vaccines and protecting millions of children from preventable diseases worldwide. Through a combination of innovative financing mechanisms and direct contributions, Spain has committed a total of €464 million (US$ 508 million) to support Gavi’s mission.
From 2006 through 2025, Spain committed €286 million (US$ 300 million) through the International Finance Facility for Immunisation (IFFIm) and €44.5 million (US$ 58.5 million) in direct contributions to Gavi and the Gavi COVAX Advance Market Commitment (AMC). In addition, Spain’s Autonomous Communities contributed €2.5 million (US$ 3.5 million).
Beyond financial support, Spain has demonstrated strong international leadership in global health by hosting Gavi’s Mid-Term Review Conference in Madrid in 2023, bringing together partners to assess, progress and reinforce collective efforts towards Gavi’s 2021–2025 strategic goals.
Most recently, at Gavi’s high-level pledging summit in Brussels in June 2025, Spain reaffirmed its commitment to global immunisation with a €130 million (US$ 146 million) pledge for Gavi’s 2026–2030 strategic period.
*Local currency
†Proceeds are the funds that Gavi receives from donor commitments, either through direct donor payments, funding raised in advance against future donor pledges through IFFIm, or AMC funds released by the World Bank.
Hover over the bar chart above to view the data
Direct Contributions (including Matching Fund)
Non-US$ contributions are converted to US$ as follows:
IFFIm Contributions
Non-US$ contributions are converted to US$ as follows: